Meloxicam 钠盐水合物已被证明可消除胸腺素诱导的大鼠肝脏中细胞因子和NGF的增加，并抑制肿瘤生长。Meloxicam 可能能够拮抗恶病质。Meloxicam 是一种非甾体抗炎药（NSAID），相对于Cox-1（cyclooxygenase-1）抑制作用，其对Cox-2（cyclooxygenase-2）的抑制作用具有300倍的选择性。 Meloxicam sodium salt hydrate has been shown to abolish thymulin-induced increases of cytokines and NGF in the liver of rats and displays tumor growth suppression. Meloxicam may be capable of antagonizing cachexia|in vitro|. Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) that shows 300-fold selectivity for Cox-2 (cyclooxygenase-2) inhibition versus Cox-1(cyclooxygenase-1) inhibition.